Tutorial
Robinhood Chain
…
Wallet
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Telegram alerts
Tutorial
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Alerts on Telegram
Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Telegram alerts
Tutorial
Seaport Therapeutics, Inc. (SPTX) · INSIDER
Data sources
SEC Form 4
22m ago
House PTR
21m ago
SEC 13F
21m ago
Robinhood Chain
21m ago
Public company
Seaport Therapeutics, Inc.
SPTX
CIK 0002042347
EDGAR filings
Open in network
○
Watch SPTX
Price
$20.26
1 year
+2.1%
Disclosed transactions
1
Buys / sells
0 / 0
Max Insider Score
22
Connections with evidence
2
Customize layout
SPTX · disclosed activity on price
Disclosed transactions
Score
Actor
Security
Side
Value
Executed
Disclosed
Lag
Source
Evidence
22
ZD
Zohar Daphne
Director, Chief Executive Officer
SPTX
Seaport Therapeutics, Inc.
Gift
G
—
100.0K sh
Nov 10, 2026
Nov 13, 2026
Verified connections
In industry
evidence
Pharmaceuticals, devices & health services
SEC SIC 2834 · Pharmaceutical Preparations · Nov 13, 2026
← Insider of
evidence
Zohar Daphne
Director, Chief Executive Officer · Nov 13, 2026
traded Nov 10, 2026
+3d
SEC Form 4
Evidence
Evidence
Close
Disclosed trades
TradingView